
Lcmika 250mg Injection
Marketer
Loremchem Pharmaceutical
Salt Composition
Amikacin (250mg)
Overview Lcmika 250mg Injection
The antibiotic injection, Lcmika 250mg, combats a broad spectrum of bacterial infections, encompassing urinary tract, bone, joint, lung (such as pneumonia), brain, and bloodstream infections. Prophylactically, it's also administered to hospitalized individuals to avert infections. Its mechanism involves inhibiting bacterial proliferation. Administered intravenously (IV drip) or via intramuscular injection by a healthcare professional only – self-administration is strictly prohibited – it requires adherence to a regular, evenly-spaced dosage schedule as directed. Complete the prescribed course, even with symptom improvement; premature cessation may result in relapse or infection exacerbation. Common adverse effects include injection site reactions and elevated blood urea nitrogen. Persistent side effects or treatment inefficacy necessitate consultation with your physician. High doses may rarely cause vertigo, nephrotoxicity, and hearing impairment. Strict adherence to your doctor's instructions is crucial, potentially including regular kidney function, hearing, and urinalysis. Pregnancy is a contraindication; inform your doctor of pregnancy, pregnancy intentions, or breastfeeding.
Uses of Lcmika 250mg Injection
Infections caused by bacteria
Major Benefits of Lcmika 250mg Injection:
Administering this medication will be performed by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Lcmika 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Lcmika 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Lcmika 250mg Injection works:
Lcmika 250mg Injection is a bacterial growth inhibitor, a type of antibiotic. Its mechanism of action involves blocking the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Lcmika 250mg Injection presents no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Lcmika 250mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Administration of Lcmika 250mg Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Administration of Lcmika 250mg Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Administering Lcmika 250mg Injection requires careful consideration for individuals with impaired renal function. Dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Lcmika 250mg Injection appears safe for use in individuals with hepatic impairment. Existing evidence indicates dose modification of Lcmika 250mg Injection may be unnecessary in this population. Physician consultation is recommended.
What if you forget to take Lcmika 250mg Injection :
Omit a scheduled Lcmika 250mg Injection? Seek your physician's advice.
Facts to Know About Lcmika 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
| Action Category | Aminoglycoside antibiotics |
